Blood plasma is a necessary resource to produce life-saving medicine. Because people are the only source, donors are often ...

- This is the first time the plasma industry has partnered with a government in a groundbreaking global public-private alliance to achieve plasma medicine self-sufficiency, a game-changing model that ...

Plasma donation is a painless procedure that thousands of people do each day. It is a great way to take a break in the middle of the day while helping others! All donors receive a thorough health ...

- The operation aligns with Grifols' commitment to helping countries reach self-sufficiency of life-sustaining plasma-derived medicines According to Víctor Grífols Deu, co-CEO of Grifols, "This deal ...

- The combination of Grifols and Talecris will create a diversified, global provider of life-saving and life enhancing plasma protein therapeutics built on the strong global presence of Grifols and ...

Spanish plasma-derived medicines company Grifols today announced the appointment of Tomás Dagá, Grifols’ board member, as ...

CHAPEL HILL — Americans who have recovered from COVID-19 may help save others from the disease by donating their convalescent plasma at the University of North Carolina in Chapel Hill, or at plasma ...

The addition of the Clayton site in 2011 marked a new milestone for Grifols (GRFS), turning the company into a top-three plasma industry leader and setting the stage for sustained business growth The ...

BARCELONA, Spain, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a global healthcare company and leading producer of plasma-derived medicines, today announced it ...

Market share in the global plasma-derived protein business is concentrated among a small number of global players, and Grifols lifted itself to the level of competitors Takeda and CSL with the $3.7 ...

The giant blood plasma processing company Grifols on Monday said it has agreed to buy Alkahest, a Silicon Valley startup founded by Genentech alums that’s betting that proteins in plasma can fight ...

- Grifols makes a significant investment to become the only large-scale commercial manufacturer of plasma products in Canada, with a fractionation capacity of 1.5 million liters/year - The operation ...